{
    "SPADE_N_13995": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13995",
            "Peptide Name": "SB2 (Synthetic AMPs, Thanatin variant, Arg-rich; 1S=S, UCSS1a)",
            "Source": "amino acid substitution, insects, animal-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GSRRPVPIIYCNRRTGRCQRI",
            "Sequence Length": 21,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antiviral",
                "Anti-HIV"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2501.94,
            "PI": 11.71,
            "Hydrophobicity": -0.86,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2011",
                    "Reference": "J AIDS Clinic Res S2:003. doi:10.4172/2155-6113.S2-003.Wang HIV screen project",
                    "Title": "De Novo Design of Antiviral and Antibacterial Peptides with \nVarying Loop Structures"
                }
            ],
            "Frequent Amino Acids": "RIC",
            "Absent Amino Acids": "ADEFHKLMOUW",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 14,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "Net Charge": 6,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is poorly similar (85.71%) toSB1. R: 29%; I: 14%.Chemical modification:  one disulfide bond C11-C18.Activity: inhibited Human Immunodeficiency Virus Type 1 HIV-1IIIB (EC50 3.33 ug/ml).Toxicity: TC50 >100 ug/ml in CEM-SS cells.SAR: Compared to SB1, the increase of anti-HIV activity of this RR variant can be attributed to additional arginines as we observed previously (Wang et al., 2010.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_00380",
                    "Similarity": 0.875,
                    "Sequence": "VPIIYCNRRTGKCQRM"
                },
                {
                    "SPADE_ID": "SPADE_N_14506",
                    "Similarity": 0.8666666666666667,
                    "Sequence": "PIIYCNRRTGKCQRM"
                },
                {
                    "SPADE_ID": "SPADE_UN_26302",
                    "Similarity": 0.8666666666666667,
                    "Sequence": "PIIYCNRRTGKCQRM"
                }
            ]
        }
    }
}